Aankondiging • Sep 20
Héroux-Devtek Expects to Delist from TSX Subject to the terms of the Arrangement Agreement and the approval of the Arrangement Resolution by the Shareholders at the Meeting in the manner required by the Interim Order, Héroux-Devtek Inc. will make an application to the Court for the Final Order. The application for the Final Order approving the Arrangement is expected to take place before the Superior Court of Quebec (Commercial Division), sitting in the district of Montreal, on September 16, 2024 See Appendix E for the notice of presentation of the Final Order. At the hearing, any Shareholder and any other interested party who wishes to participate or to be represented or present evidence or argument may do so, subject to filing with the Court and serving upon the Corporation a notice of appearance together with any evidence or materials that such party intends to present to the Court, in the timelines and in the manner described in the Interim Order. The Corporation expects that the Shares will be delisted from the TSX promptly following the Effective Date. Following the Effective Date, it is expected that the Purchaser will cause the Corporation to apply to cease to be a reporting issuer under the Securities Laws of each province and territory of Canada. Major Estimate Revision • Aug 13
Consensus EPS estimates increase by 17% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from CA$685.9m to CA$711.0m. EPS estimate increased from CA$1.38 to CA$1.62 per share. Net income forecast to grow 24% next year vs 38% growth forecast for Aerospace & Defense industry in Canada. Consensus price target of CA$30.25 unchanged from last update. Share price was steady at CA$31.19 over the past week. Reported Earnings • Aug 07
First quarter 2025 earnings: EPS and revenues exceed analyst expectations First quarter 2025 results: EPS: CA$0.37 (up from CA$0.12 in 1Q 2024). Revenue: CA$174.0m (up 24% from 1Q 2024). Net income: CA$12.5m (up 216% from 1Q 2024). Profit margin: 7.2% (up from 2.8% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 10%. Earnings per share (EPS) also surpassed analyst estimates by 54%. Revenue is forecast to grow 5.5% p.a. on average during the next 3 years, compared to a 9.6% growth forecast for the Aerospace & Defense industry in Canada. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 11
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to CA$30.95, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 15x in the Aerospace & Defense industry in Canada. Total returns to shareholders of 81% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CA$54.67 per share. Major Estimate Revision • May 29
Consensus EPS estimates increase by 21% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from CA$651.3m to CA$681.7m. EPS estimate increased from CA$1.10 to CA$1.34 per share. Net income forecast to grow 18% next year vs 35% growth forecast for Aerospace & Defense industry in Canada. Consensus price target up from CA$24.38 to CA$30.25. Share price was steady at CA$22.66 over the past week. Reported Earnings • May 23
Full year 2024 earnings: EPS and revenues exceed analyst expectations Full year 2024 results: EPS: CA$1.13 (up from CA$0.40 in FY 2023). Revenue: CA$629.8m (up 16% from FY 2023). Net income: CA$38.3m (up 177% from FY 2023). Profit margin: 6.1% (up from 2.5% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 36%. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Aerospace & Defense industry in Canada. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Aankondiging • May 22
Héroux-Devtek Inc., Annual General Meeting, Aug 06, 2024 Héroux-Devtek Inc., Annual General Meeting, Aug 06, 2024. Aankondiging • Apr 23
Héroux-Devtek Inc. to Report Q4, 2024 Results on May 22, 2024 Héroux-Devtek Inc. announced that they will report Q4, 2024 results Pre-Market on May 22, 2024 Price Target Changed • Apr 16
Price target increased by 7.5% to CA$24.50 Up from CA$22.80, the current price target is an average from 5 analysts. New target price is 26% above last closing price of CA$19.51. Stock is up 53% over the past year. The company is forecast to post earnings per share of CA$0.82 for next year compared to CA$0.40 last year. Reported Earnings • Feb 10
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Third quarter 2024 results: EPS: CA$0.27 (up from CA$0.052 in 3Q 2023). Revenue: CA$163.5m (up 16% from 3Q 2023). Net income: CA$8.98m (up 407% from 3Q 2023). Profit margin: 5.5% (up from 1.3% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 9.9%. Earnings per share (EPS) also surpassed analyst estimates by 66%. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Aerospace & Defense industry in Canada. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Feb 08
Consensus EPS estimates increase by 26% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from CA$593.7m to CA$617.0m. EPS estimate increased from CA$0.655 to CA$0.825 per share. Net income forecast to grow 89% next year vs 34% growth forecast for Aerospace & Defense industry in Canada. Consensus price target up from CA$19.50 to CA$22.80. Share price rose 13% to CA$17.25 over the past week. Price Target Changed • Feb 07
Price target increased by 7.3% to CA$20.70 Up from CA$19.30, the current price target is an average from 5 analysts. New target price is 25% above last closing price of CA$16.55. Stock is up 20% over the past year. The company is forecast to post earnings per share of CA$0.81 for next year compared to CA$0.40 last year. Aankondiging • Jan 17
Héroux-Devtek Inc. to Report Q3, 2024 Results on Feb 07, 2024 Héroux-Devtek Inc. announced that they will report Q3, 2024 results Pre-Market on Feb 07, 2024 Reported Earnings • Nov 12
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Second quarter 2024 results: EPS: CA$0.14. Revenue: CA$141.5m (up 6.6% from 2Q 2023). Net income: CA$4.63m (down 3.6% from 2Q 2023). Profit margin: 3.3% (down from 3.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) also missed analyst estimates by 3.4%. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 9.2% growth forecast for the Aerospace & Defense industry in Canada. Aankondiging • Oct 19
Héroux-Devtek Inc. to Report Q2, 2024 Results on Nov 10, 2023 Héroux-Devtek Inc. announced that they will report Q2, 2024 results Pre-Market on Nov 10, 2023 New Risk • Aug 09
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 3.1% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (3.1% operating cash flow to total debt). Minor Risk Profit margins are more than 30% lower than last year (3.0% net profit margin). Reported Earnings • Aug 08
First quarter 2024 earnings: EPS and revenues exceed analyst expectations First quarter 2024 results: EPS: CA$0.12 (up from CA$0.028 in 1Q 2023). Revenue: CA$140.7m (up 23% from 1Q 2023). Net income: CA$3.97m (up 311% from 1Q 2023). Profit margin: 2.8% (up from 0.8% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.7%. Earnings per share (EPS) also surpassed analyst estimates by 23%. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Aerospace & Defense industry in Canada. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Jun 08
Now 20% undervalued Over the last 90 days, the stock is up 4.9%. The fair value is estimated to be CA$17.68, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.9% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 18% in 2 years. Earnings is forecast to grow by 135% in the next 2 years. Aankondiging • May 26
Héroux-Devtek Inc., Annual General Meeting, Aug 08, 2023 Héroux-Devtek Inc., Annual General Meeting, Aug 08, 2023. Buying Opportunity • May 21
Now 20% undervalued Over the last 90 days, the stock is up 4.7%. The fair value is estimated to be CA$17.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.9% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 18% in 2 years. Earnings is forecast to grow by 135% in the next 2 years. Reported Earnings • May 19
Full year 2023 earnings: EPS and revenues exceed analyst expectations Full year 2023 results: EPS: CA$0.40 (down from CA$0.91 in FY 2022). Revenue: CA$543.6m (up 1.4% from FY 2022). Net income: CA$13.8m (down 57% from FY 2022). Profit margin: 2.5% (down from 6.1% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 14%. Revenue is forecast to grow 8.1% p.a. on average during the next 2 years, compared to a 9.5% growth forecast for the Aerospace & Defense industry in Canada. Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Feb 15
Consensus EPS estimates fall by 40% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from CA$0.588 to CA$0.353 per share. Revenue forecast steady at CA$535.4m. Net income forecast to grow 4.9% next year vs 21% growth forecast for Aerospace & Defense industry in Canada. Consensus price target down from CA$20.17 to CA$18.25. Share price fell 15% to CA$13.15 over the past week. Reported Earnings • Feb 09
Third quarter 2023 earnings: Revenues in line with analyst expectations Third quarter 2023 results: Revenue: CA$140.9m (up 7.4% from 3Q 2022). Net income: CA$1.77m (down 73% from 3Q 2022). Profit margin: 1.3% (down from 4.9% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Revenue is forecast to grow 9.1% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Aerospace & Defense industry in Canada. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Major Estimate Revision • Feb 08
Consensus EPS estimates fall by 42% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from CA$0.59 to CA$0.34 per share. Revenue forecast steady at CA$534.7m. Net income forecast to shrink 8.3% next year vs 21% growth forecast for Aerospace & Defense industry in Canada . Consensus price target down from CA$20.33 to CA$19.50. Share price fell 9.1% to CA$13.81 over the past week. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CA$16.20, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 23x in the Aerospace & Defense industry in North America. Total loss to shareholders of 24% over the past three years. Aankondiging • Jan 19
Héroux-Devtek Inc. to Report Q3, 2023 Results on Feb 08, 2023 Héroux-Devtek Inc. announced that they will report Q3, 2023 results Pre-Market on Feb 08, 2023 Reported Earnings • Nov 16
Second quarter 2023 earnings: EPS and revenues exceed analyst expectations Second quarter 2023 results: EPS: CA$0.14 (down from CA$0.21 in 2Q 2022). Revenue: CA$132.7m (up 1.1% from 2Q 2022). Net income: CA$4.80m (down 38% from 2Q 2022). Profit margin: 3.6% (down from 5.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) also surpassed analyst estimates by 67%. Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 9.8% growth forecast for the Aerospace & Defense industry in Canada. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 12
Second quarter 2023 earnings: EPS and revenues exceed analyst expectations Second quarter 2023 results: EPS: CA$0.14 (down from CA$0.21 in 2Q 2022). Revenue: CA$132.7m (up 1.1% from 2Q 2022). Net income: CA$4.80m (down 38% from 2Q 2022). Profit margin: 3.6% (down from 5.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) also surpassed analyst estimates by 67%. Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Aerospace & Defense industry in Canada. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Aankondiging • Nov 01
Héroux-Devtek Inc. to Report Q2, 2023 Results on Nov 11, 2022 Héroux-Devtek Inc. announced that they will report Q2, 2023 results Pre-Market on Nov 11, 2022 Major Estimate Revision • Aug 12
Consensus EPS estimates fall by 28% The consensus outlook for earnings per share (EPS) in 2023 has deteriorated. 2023 revenue forecast decreased from CA$580.6m to CA$533.3m. EPS estimate also fell from CA$1.02 per share to CA$0.74 per share. Net income forecast to grow 3.9% next year vs 28% growth forecast for Aerospace & Defense industry in Canada. Consensus price target down from CA$23.57 to CA$21.80. Share price rose 3.1% to CA$14.01 over the past week. Price Target Changed • Aug 09
Price target decreased to CA$21.80 Down from CA$23.57, the current price target is an average from 6 analysts. New target price is 61% above last closing price of CA$13.58. Stock is down 26% over the past year. The company is forecast to post earnings per share of CA$0.82 for next year compared to CA$0.91 last year. Reported Earnings • Aug 06
First quarter 2023 earnings: EPS and revenues miss analyst expectations First quarter 2023 results: EPS: CA$0.03 (down from CA$0.19 in 1Q 2022). Revenue: CA$114.1m (down 9.6% from 1Q 2022). Net income: CA$965.0k (down 86% from 1Q 2022). Profit margin: 0.8% (down from 5.4% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 14%. Earnings per share (EPS) also missed analyst estimates by 85%. Over the next year, revenue is forecast to grow 5.5%, compared to a 46% growth forecast for the industry in Canada. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Aankondiging • Jul 08
Héroux-Devtek Inc. to Report Q1, 2023 Results on Aug 05, 2022 Héroux-Devtek Inc. announced that they will report Q1, 2023 results Pre-Market on Aug 05, 2022 Recent Insider Transactions Derivative • Jun 17
Insider exercised options to buy CA$74k worth of stock. On the 10th of June, Jean Gravel exercised options to buy 5k shares at a strike price of around CA$10.71, costing a total of CA$54k. This transaction amounted to 9.5% of their direct individual holding at the time of the trade. Since September 2021, Jean's direct individual holding has increased from 50.73k shares to 52.64k. Company insiders have collectively bought CA$1.1m more than they sold, via options and on-market transactions, in the last 12 months. Recent Insider Transactions • Jun 01
CFO & VP recently sold CA$383k worth of stock On the 27th of May, Stéphane Arsenault sold around 25k shares on-market at roughly CA$15.32 per share. This was the largest sale by an insider in the last 3 months. Stéphane has been a seller over the last 12 months, reducing personal holdings by CA$556k. Aankondiging • May 21
Héroux-Devtek Inc., Annual General Meeting, Aug 05, 2022 Héroux-Devtek Inc., Annual General Meeting, Aug 05, 2022. Reported Earnings • May 19
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: EPS: CA$0.91 (up from CA$0.55 in FY 2021). Revenue: CA$536.1m (down 6.1% from FY 2021). Net income: CA$32.5m (up 62% from FY 2021). Profit margin: 6.1% (up from 3.5% in FY 2021). The increase in margin was driven by lower expenses. Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) also surpassed analyst estimates by 11%. Over the next year, revenue is forecast to grow 8.4%, compared to a 57% growth forecast for the industry in Canada. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Major Estimate Revision • Feb 16
Consensus EPS estimates fall by 13% The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CA$561.7m to CA$531.8m. EPS estimate also fell from CA$0.94 per share to CA$0.83 per share. Net income forecast to grow 18% next year vs 17% growth forecast for Aerospace & Defense industry in Canada. Consensus price target broadly unchanged at CA$24.25. Share price fell 3.5% to CA$17.06 over the past week. Reported Earnings • Feb 11
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Third quarter 2022 results: EPS: CA$0.18 (down from CA$0.24 in 3Q 2021). Revenue: CA$131.1m (down 13% from 3Q 2021). Net income: CA$6.47m (down 25% from 3Q 2021). Profit margin: 4.9% (down from 5.7% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 9.3%. Earnings per share (EPS) also missed analyst estimates by 22%. Over the next year, revenue is forecast to grow 5.2%, compared to a 37% growth forecast for the industry in Canada. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Buying Opportunity • Feb 04
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 11%. The fair value is estimated to be CA$22.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.5% per annum over the last 3 years. The company has become profitable over the last year. Recent Insider Transactions Derivative • Nov 19
President exercised options to buy CA$568k worth of stock. On the 15th of November, Martin Brassard exercised options to buy 30k shares at a strike price of around CA$11.45, costing a total of CA$344k. This transaction amounted to 16% of their direct individual holding at the time of the trade. Since December 2020, Martin's direct individual holding has increased from 180.30k shares to 190.77k. Company insiders have collectively bought CA$648k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • Nov 14
Second quarter 2022 earnings released: EPS CA$0.21 (vs CA$0.11 in 2Q 2021) The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2022 results: Revenue: CA$131.3m (down 4.2% from 2Q 2021). Net income: CA$7.76m (up 99% from 2Q 2021). Profit margin: 5.9% (up from 2.8% in 2Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings. Recent Insider Transactions Derivative • Aug 13
Executive Chairman of the Board exercised options to buy CA$325k worth of stock. On the 11th of August, Gilles Labbé exercised options to buy 18k shares at a strike price of around CA$11.31, costing a total of CA$201k. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. Since December 2020, Gilles has owned 3.73m shares directly. Company insiders have collectively bought CA$477k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • Aug 12
First quarter 2022 earnings released: EPS CA$0.19 (vs CA$0.038 loss in 1Q 2021) The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2022 results: Revenue: CA$126.2m (down 1.7% from 1Q 2021). Net income: CA$6.84m (up CA$8.24m from 1Q 2021). Profit margin: 5.4% (up from net loss in 1Q 2021). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Recent Insider Transactions Derivative • Jul 03
President exercised options to buy CA$188k worth of stock. On the 25th of June, Martin Brassard exercised options to buy 10k shares at a strike price of around CA$11.31, costing a total of CA$118k. This transaction amounted to 5.8% of their direct individual holding at the time of the trade. Since December 2020, Martin has owned 180.30k shares directly. Company insiders have collectively bought CA$131k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • May 22
Full year 2021 earnings released: EPS CA$0.55 (vs CA$1.38 loss in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: CA$570.7m (down 6.9% from FY 2020). Net income: CA$20.1m (up CA$70.2m from FY 2020). Profit margin: 3.5% (up from net loss in FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance. Price Target Changed • May 21
Price target increased to CA$22.00 Up from CA$20.25, the current price target is an average from 4 analysts. New target price is 28% above last closing price of CA$17.23. Stock is up 83% over the past year. Is New 90 Day High Low • Mar 13
New 90-day high: CA$16.46 The company is up 19% from its price of CA$13.85 on 11 December 2020. The Canadian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Aerospace & Defense industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$17.56 per share. Aankondiging • Feb 12
Héroux-Devtek Inc. Appoints Didier Evrard as Director Héroux-Devtek Inc. announced the appointment of Mr. Didier Evrard as Director of the Corporation. A 40-year European aerospace veteran, Mr. Evrard most recently served as Executive Vice President and Head of Programs at Airbus Commercial Aircraft, a position he held for nearly five years. In this capacity, he was responsible for all civil aircraft programs, ensuring their profitability and leading product policy. Reported Earnings • Feb 07
Third quarter 2021 earnings released: EPS CA$0.24 (vs CA$0.24 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and revenues, although profit margins were improved. Third quarter 2021 results: Revenue: CA$150.3m (down 4.4% from 3Q 2020). Net income: CA$8.60m (down 2.3% from 3Q 2020). Profit margin: 5.7% (up from 5.6% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 85% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Analyst Estimate Surprise Post Earnings • Feb 07
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 8.1%. Earnings per share (EPS) also surpassed analyst estimates by 71%. Over the next year, revenue is expected to shrink by 2.3% compared to a 499% growth forecast for the Aerospace & Defense industry in Canada. Price Target Changed • Feb 07
Price target raised to CA$18.83 Up from CA$17.50, the current price target is an average from 5 analysts. The new target price is 22% above the current share price of CA$15.40. As of last close, the stock is down 28% over the past year. Is New 90 Day High Low • Feb 06
New 90-day high: CA$15.40 The company is up 41% from its price of CA$10.96 on 06 November 2020. The Canadian market is up 14% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Aerospace & Defense industry, which is up 43% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$20.55 per share. Aankondiging • Jan 14
Héroux-Devtek Inc. to Report Q3, 2021 Results on Feb 05, 2021 Héroux-Devtek Inc. announced that they will report Q3, 2021 results Pre-Market on Feb 05, 2021 Is New 90 Day High Low • Jan 07
New 90-day high: CA$14.94 The company is up 44% from its price of CA$10.41 on 08 October 2020. The Canadian market is up 11% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Aerospace & Defense industry, which is up 57% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$14.95 per share. Price Target Changed • Nov 17
Price target raised to CA$16.33 Up from CA$14.67, the current price target is an average from 5 analysts. The new target price is 13% above the current share price of CA$14.44. As of last close, the stock is down 24% over the past year. Analyst Estimate Surprise Post Earnings • Nov 15
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 6.6%. Earnings per share (EPS) also surpassed analyst estimates by 47%. Over the next year, revenue is expected to shrink by 5.6% compared to a 421% growth forecast for the Aerospace & Defense industry in Canada. Is New 90 Day High Low • Nov 10
New 90-day high: CA$12.29 The company is up 9.0% from its price of CA$11.30 on 12 August 2020. The Canadian market is up 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Aerospace & Defense industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$12.62 per share. Aankondiging • Oct 28
Héroux-Devtek Inc. to Report Q2, 2021 Results on Nov 13, 2020 Héroux-Devtek Inc. announced that they will report Q2, 2021 results on Nov 13, 2020 Aankondiging • Oct 06
Héroux-Devtek Inc.'s CESA subsidiary in Spain Receives Major Multi-Year Supply Agreement with Boeing for the Manufacture of Several Actuation Components Héroux-Devtek Inc. announced that its CESA subsidiary in Spain has been awarded a major multi-year contract by The Boeing Company to manufacture new actuation components for several commercial aircraft platforms. The contract scope will include the supply of production requirements and spare parts for the 787, 777, 777X, 767 (including the Tanker version), and 747. Is New 90 Day High Low • Oct 01
New 90-day low: CA$9.24 The company is down 12% from its price of CA$10.50 on 03 July 2020. The Canadian market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Aerospace & Defense industry, which is down 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$11.84 per share. Aankondiging • Jul 31
Héroux-Devtek Inc. to Report Q1, 2021 Results on Aug 07, 2020 Héroux-Devtek Inc. announced that they will report Q1, 2021 results at 9:00 AM, Eastern Standard Time on Aug 07, 2020